BIOA
Financials
- Market Capitalization 462.64 M
- Employee 62
- Founded 2015
- CEO N/A
- Website www.bioagelabs.com
- Headquarter Delaware, United States
- FIGI BBG00HBTB0M9
- Industry Drug Manufacturers—Specialty & Generic
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2836 |  EOLS Evolus, Inc. - Common Stock | 8.88 USD | +1.14% | +6.35% | +41.63% | +18.56% | 586.53 M USD | ||
| 2958 |  KMDA Kamada Ltd. - Ordinary Shares | 8.26 USD | -1.43% | +2.99% | +17.33% | +17.83% | 476.49 M USD | ||
| 3037 |  CGC Canopy Growth Corporation - Common Shares | 1.01 USD | -2.88% | -3.81% | +12.22% | -43.89% | 427.27 M USD | ||
| 3099 |  TKNO Alpha Teknova, Inc. - Common Stock | 7.31 USD | +1.25% | +3.25% | +43.33% | +69.21% | 392.46 M USD |
Frequently asked questions about BioAge Labs, Inc. Common Stock
What is the BioAge Labs, Inc. Common Stock stock price today?
The current price of BioAge Labs, Inc. Common Stock (BIOA) is 10.08. Over the past 24 hours, the stock has changed by +2.44%. Follow the BIOA chart for real-time price dynamics.
What is the stock ticker of BioAge Labs, Inc. Common Stock?
BioAge Labs, Inc. Common Stock trades under the ticker BIOA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is BioAge Labs, Inc. Common Stock stock going up?
BIOA has changed by +3.07% over the last week, -54.10% over the last month, and +32.63% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of BioAge Labs, Inc. Common Stock?
BioAge Labs, Inc. Common Stock currently has a market capitalization of 462.64 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were BioAge Labs, Inc. Common Stock earnings last quarter?
Last quarter, BioAge Labs, Inc. Common Stock reported earnings of -0.58 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was BioAge Labs, Inc. Common Stock revenue for the last quarter?
BioAge Labs, Inc. Common Stock reported quarterly revenue of 2.45 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was BioAge Labs, Inc. Common Stock net income for the last quarter?
BioAge Labs, Inc. Common Stock reported net income of -26.1 M for the last quarter. The previous quarter showed -22.25 M, which means net income changed by -17.27%.
How many employees does BioAge Labs, Inc. Common Stock have?
As of the latest available data, BioAge Labs, Inc. Common Stock has 62 employees. Workforce size can provide additional context about the company's scale and operations.
What is BioAge Labs, Inc. Common Stock EBITDA?
BioAge Labs, Inc. Common Stock EBITDA is -29.83 M, and its EBITDA margin is -1 216.89%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy BioAge Labs, Inc. Common Stock stock?
You can buy BioAge Labs, Inc. Common Stock (BIOA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in BioAge Labs, Inc. Common Stock stock?
Investing in BioAge Labs, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BIOA chart and related analysis on metatrader.com as part of your research.